Application of monascus purpureus mutant strain in fermentation production of functional active substances
By gene editing, knocking out histone H3K9 methyltransferase gene, the mutant strain of Aspergillus plexus was constructed, and fermented under solid fermentation conditions, solving the problem of low yield of Monacorin K in the red lemon products, realizing Monacorin The increase in yields of K, flavonoids and phenolics provides higher application value and safety.
Patent Information
- Application Number
- CN202410963742.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-18
- Publication Date
- 2024-11-01
AI Technical Summary
The yield of monacorin K in existing red citrus products is relatively low, and it is difficult to maintain or increase the yield of other functional active substances at the same time when increasing the yield of monacorin K, especially the yield of flavonoids and phenols.
Through gene editing technology, the histone H3K9 methyltransferase gene of Aspergillus Rheumata was knocked out by CRISPR/Cas9 system to construct the mutant strain Δmpclr4 of Aspergillus Rheumata, hydrolysis of mixed enzymes was used to prepare highly active protoplasts, and the solid fermentation medium was used to ferment. fermentation is carried out to achieve high yields of monacorine K, flavonoids and phenols.
The successful increase in the yield of monacorin K, flavonoids and phenols has provided higher application value, and the method is highly safe and suitable for commercial applications.
Smart Images

Figure CN118879804A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of food nutrition, and in particular to the application of a mutant strain of Monascus pubescens in the fermentation production of functional active substances. Background Art
[0002] With the changes in human lifestyles in modern society, the morbidity and mortality of cardiovascular and cerebrovascular diseases are rising, and hyperlipidemia is a risk factor for cardiovascular and cerebrovascular diseases. At present, statins are important cholesterol-lowering drugs for the treatment of hyperlipidemia-related diseases, and they occupy a large market share. Modern medical research shows that monacolin K (MK) produced by Monascus fermentation has a similar chemical structure to lovastatin, and can directly play a lipid-lowering role without liver hydrolysis. It has a higher safety while reducing side effects while exerting medicinal activity. As functional microbial fermentation gradually shows its advantages in flavor enhancement and active component synthesis, consumers' demand for traditional medicinal and edible products is gradually increasing, and Monascus products are receiving more and more attention.
[0003] The yield of active ingredients, especially monacolin K, in red yeast rice products obtained by fermentation with natural Monascus purpurogenum is low. As red yeast rice products receive more and more attention, increasing the yield of active ingredients, especially monacolin K, in red yeast rice products and shortening the fermentation cycle are important research directions for the production of red yeast rice products.
[0004] Through traditional genetic breeding techniques, high-yield and stress-resistant strains can be obtained. Therefore, the purpose of modern genetic engineering breeding is to use gene editing to improve strains and obtain genetically stable strains. The development of efficient gene editing technology and multi-gene editing tools can undoubtedly effectively improve the efficiency of genetic engineering breeding. In recent years, the sequence-specific nuclease (SSNs)-CRISPR / Cas9 system composed of DNA recognition domain and nuclease domain has been developed and applied to filamentous fungal gene editing. The constitutive strong promoter gpdA (PgpdA) and terminator trpC (TtrpC) are used to ensure the release of transcripts containing single guide RNA (sgRNA) in vivo. The plasmid constructed with the Aspergillus nidulans AMA1 sequence as the skeleton can replicate independently in vivo, and the introduction of fungal selection markers facilitates the subsequent screening of mutant strains. So far, such a universal CRISPR / Cas9 gene editing system has been successfully applied to gene editing of various filamentous fungi. In Aspergillus niger, due to the recyclability of the selection marker, multi-gene editing mediated by the CRISPR / Cas9 system was successfully achieved through iterative recycling. Moreover, through iterative recycling of plasmids, mutant strains without the introduction of exogenous genetic material can be obtained, which has better safety and commercial application value.
[0005] Through the joint analysis of genomics and molecular biology, it was found that the synthesis of MK in Monascus is catalyzed by a biosynthetic gene cluster of 9 genes with known functions. The transcription of these genes is regulated at multiple levels. Among them, histones are the core proteins that constitute chromatin. Changing the interaction between DNA and histones by chemical modification can affect gene expression. In purple Monascus, the inactivation of H3K4 methyltransferase leads to obvious growth inhibition, which hinders the synthesis of citrinin and pigments, indicating that histone methylation modification does affect the biosynthesis of secondary metabolites of Monascus.
[0006] However, red yeast rice products contain not only monacolin K, but also other functionally active substances. There is currently little research on how to increase the production of monacolin K without affecting the production of other functionally active substances, or even increase the production of other functionally active substances. Summary of the invention
[0007] In order to overcome the shortcomings of the above-mentioned technology, the purpose of the present invention is to provide an application of a mutant strain of Monascus pilosula in the fermentation production of functional active substances. When the mutant strain of Monascus pilosula is used for fermentation, monacolin K, flavonoids and phenols can be produced simultaneously in high yields.
[0008] To achieve the above purpose, the technical solution adopted by the present invention is as follows:
[0009] The invention discloses an application of a mutant strain of Monascus pubescens in fermentation production of functional active substances, wherein the functional active substances include one or more of monacolin K, flavonoids and phenols.
[0010] Application of a mutant strain of Monascus pubescens to improving the yield of monacolin K in a fermentation process.
[0011] In the above application, the mutant strain of Monascus pubescens uses Monascus pubescens MS-1 as the starting strain, and the sequence encoding the SET domain in the histone H3K9 methyltransferase gene mpclr4 is knocked out in the genome of Monascus pubescens MS-1; the nucleotide sequence of the mpclr4 is shown in SEQ ID NO: 1; the sequence encoding the SET domain in the mpclr4 is shown in SEQ ID NO: 2.
[0012] Preferably, during the fermentation process, the culture medium is a solid fermentation medium compounded of cereals and rice flour.
[0013] Preferably, in the solid-state fermentation medium, the mass ratio of cereals to rice flour is 1:1-3; the cereals are any one or more of black rice, germ and oats.
[0014] Preferably, in the solid-state fermentation medium, the mass ratio of cereals to rice flour is 1:1; the cereals are any one of oats and black rice.
[0015] Preferably, the method for constructing the mutant strain of Monascus pilosula is: preparing protoplasts of Monascus pilosula MS-1, and knocking out the sequence encoding the SET domain in the histone H3K9 methyltransferase gene mpclr4 in the genome of Monascus pilosula MS-1 by combining the CRISPR / Cas9 system and the protoplast transformation method.
[0016] Preferably, the protoplast preparation method is as follows: the mycelium of Monascus pubescens MS-1 is hydrolyzed by mixed enzymes, and then the protoplasts are collected and purified.
[0017] Preferably, the enzyme mixture is dissolved in an osmotic pressure stabilizer; the components in the enzyme mixture and their mass volume percentages in the osmotic pressure stabilizer are as follows: 0.4% lytic enzyme, 0.4% lyase, 1.6% cellulase, and 1.2% snailase.
[0018] Preferably, the pH of the osmotic pressure stabilizer is 5.8; the osmotic pressure stabilizer includes: 0.9M NaCl, 5mM DTT, 10mM Na 2 HPO 4 / NaH 2 PO 4 .
[0019] The above-mentioned Monascus pilosus MS-1 was disclosed in a Chinese invention with announcement number CN103468585B and invention name “A strain of Monascus pilosus and its use in preparing functional Monascus pilosus”. The Monascus pilosus MS-1 was deposited in the China Center for Type Culture Collection (abbreviated as CCTCC, address: Bayi Road, Hongshan District, Wuhan City, Hubei Province) on June 26, 2013, with a preservation number of CCTCC M2013295 and a classification name of Monascus pilosus.
[0020] Compared with the prior art, the present invention has the following beneficial effects:
[0021] The present invention first develops a scheme suitable for preparing high-quality protoplasts from Monascus, using high-speed culture to collect young mycelium and using mixed enzymes for mild hydrolysis to obtain highly active protoplasts. Secondly, gene editing using the CRISPR / Cas9 system requires the design of sgRNA targeting the target sequence region. The present invention uses a multi-platform to design sgRNA sequences, and uses Gibson Assembly to efficiently construct expression vectors containing sgRNA and Cas9 proteins for transformation. After successfully obtaining mutant strains, the transformed plasmids are removed by subculture to obtain improved strains. Finally, the present invention applies the obtained gene knockout strain Δmpclr4 to fermentation, and detects the content of natural active substances produced by fermentation with different grains as the culture matrix.
[0022] The present invention applies the CRISPR / Cas9 system that relies on protoplast transformation to the gene editing of Monascus pubescens MS-1 to produce a genetically modified strain. Since its screening marker is not integrated into the recipient genome, a high-yield MK-producing Monascus pubescens mutant strain Δmpclr4 suitable for commercial applications can be obtained. The high-yield MK-producing Monascus pubescens mutant strain Δmpclr4 obtained by the present invention can co-produce monacolin K, flavonoids and phenols when fermented in a solid fermentation medium compounded with different cereals and rice flour, thereby increasing the yield of flavonoids and phenols while increasing monacolin K. In practical applications, these natural active substances give the fermentation product a higher application value.
[0023] (1) The method of the present invention can efficiently prepare protoplasts of filamentous fungi. The mycelium is gently hydrolyzed by a mixed enzyme, and protoplasts with intact structure and high activity can be obtained in 2 hours. The method is suitable for preparing protoplasts of Aspergillus oryzae, Monascus pubescens and Monascus rubrum.
[0024] (2) The present invention applies the CRISPR / Cas9 system to Monascus pilosula for gene editing by relying on protoplast transformation.
[0025] (3) After the present invention uses the CRISPR / Cas9 system to knock out the gene, since the selection marker is not integrated into the recipient genome, the gene knockout strain Δmpclr4 without the selection marker is obtained by subculturing on a PDA medium without a selection drug. The obtained gene knockout strain Δmpclr4 is applied to MK liquid fermentation, and the strain without the selection marker also shows good fermentation ability. In addition, the gene knockout strain Δmpclr4 with high MK yield obtained by the present invention can co-produce monacolin K, flavonoids and phenols, thereby increasing the yield of flavonoids and phenols while increasing monacolin K. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] Figure 1 is a flow chart of the protoplast preparation process of the present invention;
[0027] Figure 2 It is a microscopic observation diagram of protoplasts of different filamentous fungi in a specific embodiment of the present invention;
[0028] Figure 3 This is a flow chart of using the CRISPR / Cas9 system to perform gene editing on Monascus pilosula in the present invention;
[0029] Figure 4 The PCR verification diagram and colony morphology diagram of the gene deletion strain constructed in the present invention are shown in FIG.
[0030] in, Figure 4 a is the PCR verification diagram of the CRISPR / Cas9 system deletion strain. Figure 4 b is the PCR verification diagram of ATMT deletion strain, Figure 4 c is the colony morphology of the gene-deficient strain;
[0031] Figure 5 This is a graph of MK yield in liquid fermentation of the strain of the present invention;
[0032] Figure 6 This is a graph analyzing the content of active substances produced by the mutant strain Δmpclr4 of Monascus pilosula in the present invention in the solid-state fermentation medium of different cereals and rice flour.
[0033] in, Figure 6 a is the yield analysis chart of MK, Figure 6 b is the analysis chart of total phenol content, Figure 6 c is the flavonoid content analysis chart. DETAILED DESCRIPTION
[0034] In order to better explain the present invention, the main contents of the present invention are further explained below in conjunction with the drawings and specific embodiments, but the contents of the present invention are not limited to the following embodiments.
[0035] Example 1 Construction of the mutant strain Δmpclr4 of Monascus purpurogenus based on the CRISPR / Cas9 system (I) Preparation of highly active protoplasm of Monascus purpurogenus
[0036] like Figure 1 As shown, the preparation of the highly active protoplasm of Monascus specifically comprises the following steps:
[0037] (1) Strain culture: The conidia of Monascus rubrum MS-1 cultured on PDA plate medium for 7-9 days were aseptically eluted with sterile water. The spore eluate obtained by aseptic elution was dispersed at 120 rpm for 30 min, and then filtered through 4 layers of sterile lens paper to collect the spore liquid for later use.
[0038] (2) Mycelium culture: adjust the spore solution concentration to 106 / mL, and inoculated into yeast malt extract medium (Yeast Extract Malt Extract, YEME, yeast extract 3g / L, polypeptone 5g / L, malt extract 3g / L, glucose 10g / L, sucrose 250g / L) at a 10% inoculation rate, and cultured at 30℃, 250rpm for 30h.
[0039] (3) Mycelium collection: The bacterial solution after culture in step (2) was filtered through 4 layers of lens paper to collect the flocculent mycelium, and the collected flocculent mycelium was washed twice with 10 mL of sterile osmotic pressure buffer (0.9 M NaCl, pH 5.8), and then the mycelium was dried as much as possible with sterile filter paper.
[0040] (4) Preparation of mixed enzyme hydrolyzate: The obtained mycelium is subjected to enzymatic hydrolysis to remove the cell wall and collect complete protoplasts. In order to obtain complete and high-quality protoplasts in a short time, a composite hydrolase composed of multiple enzymes is selected and the concentration of the composite enzyme is optimized for hydrolysis. The mass volume percentage of various enzymes is as follows: 0.4% of lytic enzyme (Guangdong Institute of Microbiology, China) and 0.4% of lyase (Shanghai Yuanye), 1.6% of cellulase (Shanghai Yuanye) and 1.2% of snail enzyme (Beijing Solebold). The composite enzyme is dissolved in an osmotic pressure stabilizer. The ratio of the osmotic pressure stabilizer is: 0.9M NaCl, 5mM dithiothreitol (DTT), 10mM Na 2 HPO 4 / NaH 2 PO 4 , pH 5.8.
[0041] (5) Mycelium hydrolysis: 200 mg of mycelium was evenly mixed with 10 mL of mixed enzyme hydrolysis solution, transferred to a sterile 50 mL centrifuge tube, and gently incubated for hydrolysis at 30 °C and 80 rpm for 2 h.
[0042] (6) Protoplast collection: The hydrolyzed mycelial suspension was filtered through a syringe plugged with sterile cotton wool under the action of gravity to obtain a protoplast suspension.
[0043] (7) Protoplast purification: The collected protoplast suspension was centrifuged at 2000 rpm for 5 min, the supernatant was discarded, and the precipitate was resuspended with 0.9 M NaCl. The resuspension step was repeated.
[0044] This method can be used to prepare protoplasts of Aspergillus oryzae, Monascus rubrum and Monascus rubrum. Figure 2 As shown in Figure 2, the concentration of Aspergillus oryzae protoplasts obtained under this condition was 1.25×10 6 / mL, and the protoplast concentration of Monascus pilosula was 7×106 / mL, and the protoplast concentration of Monascus rubrum was 8.755×10 6 Pieces / mL.
[0045] (II) Application of CRISPR / Cas9 system in gene editing of Monascus pilosula MS-1
[0046] like Figure 3 As shown in the figure, the process of gene editing using the CRISPR / Cas9 system in Monascus is as follows:
[0047] (1) Protoplast purification: Freshly prepared protoplasts were resuspended in freshly prepared sterile 1.2 M sorbitol solution, centrifuged at 2000 rpm for 5 min, and then washed with pre-cooled STC buffer (1.2 M sorbitol, 10 mM CaCl 2 , 10 mM Tris-HCl, pH 7.5) to resuspend the precipitate and adjust the protoplast concentration to 10 6 Pieces / mL.
[0048] (2) Protoplast transformation: 200 μL of protoplasts were gently mixed with at least 5 μg of DNA (wherein the ratio of vector to donor DNA was 1:1), and the mixture was placed on ice for 40 min. 1.25 mL of 50% PEG 4000 solution was mixed with the suspension and incubated at room temperature for 20 min.
[0049] (3) Protoplast regeneration: The transformed protoplast mixture was injected into a semisolid regeneration medium (PDA medium with a final concentration of 1.2 M sorbitol and 0.8% agar) containing 50 mg / mL kanamycin (Kan) and cultured at 30°C overnight.
[0050] (4) Transformant screening: For protoplast regeneration and transformant screening, a regeneration medium containing 0.5 mg / mL hygromycin B (PDA medium with a final concentration of 1.2 M sorbitol) was overlaid on the surface of the semisolid culture medium and cultured at 30°C until small colonies grew on the surface.
[0051] (5) Screening of gene-inactivated strains: The small colonies were further transferred to PDA containing 75 mg / L hygromycin B and cultured at 28°C for 2-3 days. The genome was extracted using the CTAB method, and multiple pairs of primers were designed to perform PCR verification on suspected positive transformants. Specific primers located on the ORF were used for PCR analysis to verify the strains that underwent site-specific gene replacement.
[0052] The PCR verification results of the CRISPR / Cas9 system deletion strain are as follows Figure 4As shown in a, the primers ORF-F1 / R1 were designed with the gene replacement region (ORF) as the target for PCR amplification. The genome of the successfully constructed knockout strain was used as a template for PCR amplification. No bands were detected, while the starting strain had bands of corresponding sizes; the primer pairs dDNA-5F / ORF-R1 and ORF-F1 / dDNA-3R were used as primers for PCR amplification. The genome of the successfully constructed knockout strain was used as a template. No bands were detected, while the starting strain had bands of corresponding sizes; the constructed knockout strain was used as a template, and the primer pair dDNA-5F / 3R was used for PCR amplification. The PCR product was significantly smaller than the PCR product amplified with the starting strain as a template. The gel electrophoresis results confirmed that the gene deletion strain was successfully constructed. The primers are shown in Table 1.
[0053] Table 1: Primers required for knockout of mpclr4 using the CRISPR / Cas9 system
[0054]
[0055] (III) Removal of selection markers in mutant strains of Monascus pilosula
[0056] The obtained Monascus pilosula mutant was subcultured on a PDA plate without hygromycin, and after each subculture, micromycelium was inoculated on a PDA plate containing hygromycin B until no microcolonies grew. A gene deletion strain without a selection marker was obtained, which was the Monascus pilosula mutant strain Δmpclr4.
[0057] (IV) Colony morphology verification of the mutant strain Δmpclr4 of Monascus pilosula
[0058] In order to analyze the practicality of constructing gene knockout strains in Monascus pubescens MS-1, the colony morphology of the mutant strain Δmpclr4 of Monascus pubescens was observed, and the gene deletion strain Δmpclr4 (ATMT) constructed by ATMT technology was used as a comparison for verification. The strain PCR verification is shown in Figure 4 b.
[0059] Colony morphology of the mutant strain Δmpclr4 of Monascus pilosula
[0060] In order to analyze the practicality of constructing gene knockout strains in Monascus pubescens MS-1, the mutant strain Δmpclr4 was inoculated on PDA and MEA medium to observe the colony morphology. The specific steps are as follows:
[0061] (1) Strain culture: Monascus purpurogenum MS-1 or the mutant strain Δmpclr4 obtained by CRISPR / Cas9 system or the gene knockout strain Δmpclr4 (ATMT) obtained by ATMT technology was inoculated into PDA medium and cultured at 28°C for 7 days for activation.
[0062] (2) Preparation of spore solution: Wash the PDA plate with sterile water, transfer the eluate to a sterile Erlenmeyer flask containing glass beads, shake at 120 rpm and 28°C for 30 min, filter the eluate with four layers of sterile lens paper, count with a hemocytometer, and adjust the spore solution concentration to 10. 5 Pieces / mL.
[0063] (3) Colony inoculation: 1 μL of conidia solution was spotted on PDA and MEA plates respectively and cultured at 28°C for 7 days. The colony color, size and morphology of Monascus MS-1, Δmpclr4 and Δmpclr4(ATMT) were observed.
[0064] like Figure 4 As shown in c, in PDA and MEA culture media, there was no significant difference in colony morphology between the knockout strains obtained by the CRISPR / Cas9 system and the ATMT technology. Compared with the starting strain Monascus purpurogenum MS-1, no obvious growth defect was observed in the mutant strain Δmpclr4.
[0065] Example 2 Fermentation production of MK by the mutant strain Δmpclr4 of Monascus pubescens
[0066] The mutant strain Δmpclr4 of Monascus pubescens is applied to liquid fermentation for producing MK. The liquid temperature-variable fermentation for producing MK based on the mutant strain Δmpclr4 of Monascus pubescens specifically comprises the following steps:
[0067] (1) Strain culture: Conidia of the knockout strain or Monascus rubrum MS-1 cultured on a PDA plate at 28°C for 7 days were collected and prepared into a spore concentration of 10 6 Spore suspension with a concentration of 100 / mL.
[0068] (2) Liquid temperature-variable fermentation for MK production: 200 μL of spore suspension was inoculated into 10 mL of seed culture medium and cultured at 30°C and 180 rpm for 30 h. Then, the pre-culture was inoculated into 100 mL of liquid fermentation medium for MK production and cultured at 30°C and 120 rpm for 3 days. Finally, the temperature was adjusted to 24°C and cultured for 10 days.
[0069] The seed culture medium formula is: glucose 50g / L, peptone 10g / L, NH 4 H 2 PO 4 2g / L, MgSO 4 7H 2 O0.5g / L, CaCl 20.1g / L, replace distilled water with potato juice (PDA without glucose and agar), pH 6.0, dispense 5mL into 50mL centrifuge tubes, seal in sterilization bags, and sterilize at 121℃ for 20min.
[0070] The formula of liquid fermentation medium for MK production is as follows: potato juice is used as the basic medium, and soybean powder (100 mesh) with a final concentration of 38.75 g / L, 30 g / L sucrose, and 0.26 g / L MgSO 4 7H 2 O, and adjust the pH to 5.5, and sterilize by moist heat at 121°C for 20 min.
[0071] (3) Sampling: Starting from the 5th day of fermentation until the 13th day of fermentation, the fermentation liquid was filtered and collected every two days, and 1 mL of the fermentation liquid was freeze-dried.
[0072] (4) MK extraction: The obtained freeze-dried sample was redissolved in 1 mL of 75% ethanol, ultrasonically extracted for 30 min, and then filtered with a 0.22 μm filter membrane for HPLC analysis to detect the MK content.
[0073] (5) Determination of MK content: The MK content test was performed on a Shimadzu LC-20AT HPLC system equipped with an SPD-M20A photodiode array detector and an Inertsil ODS-3C18 column (4.6×250 mm) for chromatographic analysis. The mobile phase was an isocratic mobile phase consisting of 0.05% phosphoric acid (pH 2.5) and acetonitrile (40:60, v / v) at a flow rate of 1 mL / min and the detection wavelength was 238 nm.
[0074] like Figure 5 As shown in the figure, the two types of gene knockout strains obtained by CRISPR / Cas9 system and ATMT technology showed similar MK production ability. With the extension of fermentation time, the production of MK gradually increased. On the 11th day, the MK production of strain MS-1 reached a maximum of 250.32μg / mL; the mutant strain Δmpclr4 showed an increased ability to produce MK. Until the end of fermentation, the MK production of mutant strain Δmpclr4 obtained by ATMT technology was 359.31μg / mL, the MK production of mutant strain Δmpclr4 containing screening markers obtained by CRISPR / Cas9 system was 369.63μg / mL, and the MK production of mutant strain Δmpclr4 without screening markers was 379.49μg / mL. The above results show that the ability of the mutant strain Δmpclr4 of Monascus pubescens to produce MK by fermentation is increased.
[0075] Example 3 Production of MK, total phenols and flavonoids by fermentation of the mutant strain Δmpclr4 of Monascus pubescens using solid-state fermentation medium prepared by mixing oats, black rice and germ with rice flour respectively
[0076] (1) Culture medium preparation
[0077] Seed culture medium: glucose 50g / L, peptone 10g / L, NH 4 H 2 PO 4 2g / L, MgSO 4 7H 2 O0.5g / L, CaCl 2 0.1 g / L, potato juice was used instead of distilled water to make up to 1 L, pH 6.0).
[0078] Cereal culture medium for fermentation: fully mix black rice, germ, oats and rice flour at a ratio of 1:1 (w / w), add pure water to adjust the water content to 20%, weigh 50 g of the above mixture into a 250 mL conical flask, sterilize it and break it up while hot to obtain a solid fermentation medium.
[0079] (2) Solid fermentation process
[0080] The spore concentration was 10 6 100 μL of the spore suspension was inoculated into 5 mL of seed culture medium, and cultured at 30° C. and 220 rpm for 30 h to obtain seed solution. The seed solution was then inoculated into different solid fermentation medium prepared in step (1), and cultured at 30° C. for 60 h, and then cultured at 24° C. for 14 d.
[0081] Comparative Example 1 Production of MK, total phenols and flavonoids by fermentation of the mutant strain Δmpclr4 of Monascus pubescens using a solid fermentation medium prepared by mixing rice bran and rice flour
[0082] The difference between Comparative Example 1 and Example 3 is that different solid-state fermentation medium is used. The preparation method of the solid-state fermentation medium of Comparative Example 1 is as follows: rice bran and rice flour are fully mixed at a ratio of 1:1 (w / w), pure water is added to adjust the water content to 20%, 50 g of the above mixture is weighed and sterilized in a 250 mL conical flask and then broken up while hot to obtain a solid-state fermentation medium.
[0083] Fermentation product detection and result analysis of Example 3 and Comparative Example 1:
[0084] (I) Sample processing
[0085] After the solid-state fermentation culture is completed, the fermentation sample is dried at 40°C and then crushed to make red yeast rice powder.
[0086] (II) Fermentation product detection
[0087] (1) MK content detection
[0088] Weigh 20.0 mg of red yeast rice powder accurately into a 2 mL centrifuge tube, add 1.5 mL of 75% (v / v) ethanol, extract by ultrasonic at 30°C for 1 h, centrifuge at 12,000 r / min for 10 min, and filter the supernatant through a 0.22 μm filter membrane for HPLC analysis. Use Shimadzu LC-20AT liquid chromatograph, inertsil ODS-3 4.6×250 mm column, mobile phase acetonitrile: water: 0.5% phosphoric acid = 60:37:3, flow rate 1.0 mL / min, injection volume 10 μL, detection wavelength 238 nm.
[0089] (2) Determination of total phenol content
[0090] Weigh 0.5g of fermented powder and add 5mL of 60% ethanol solution for ultrasonic extraction for 30min. Filter the sample and collect the filtrate for later use. Take 1mL of the extract and add 0.5mL of Folin phenol colorimetric reagent, mix thoroughly, let stand for 5min, then add 1.5mL of 20% Na 2 CO 3 After mixing, the volume was adjusted to 10 mL, reacted in a water bath at 50°C for 30 min, and the absorbance was measured at a wavelength of 760 nm. Gallic acid was used as a standard to draw a standard curve.
[0091] (3) Determination of flavonoid content
[0092] Weigh 0.5g of fermented powder and add 5mL of 95% ethanol for ultrasonic extraction for 30min, filter and dilute to 10mL. Take 1mL of the extract and add 1mL of 60% ethanol and 0.5mL of 5% NaNO 2 After fully reacting for 6 min, 0.5 mL of 10% Al(NO 3 ) 3 After fully reacting for 6 minutes, add 4 mL of 4% NaOH and dilute to a total volume of 10 mL with 60% ethanol, shake well, let stand for 30 minutes until the reaction is complete, and detect the absorbance at a wavelength of 510 nm. Use 60% ethanol to dissolve rutin as the standard solution to draw a standard curve.
[0093] 3. Conclusion
[0094] like Figure 6As shown, when fermented in the solid fermentation medium with rice bran added, the yields of MK, total phenols and flavonoids of the starting strain were 3.21 mg / g, 1.56 mg / g and 1.51 mg / g, respectively, and the yields of MK, total phenols and flavonoids of the mutant strain Δmpclr4 were 3.70 mg / g, 1.64 mg / g and 1.15 mg / g, respectively. Although the content of active substances produced by fermentation of the mutant strain Δmpclr4 was slightly increased compared with the starting strain, its total phenol production was much lower than the fermentation yield of the solid fermentation medium in Example 3. Therefore, it is preferred to use the scheme of Example 3 for fermentation.
[0095] The fermentation results in Example 3 are analyzed as follows:
[0096] MK: Figure 6 As shown in a, the yield of MK on the rice flour medium supplemented with oats is the largest, and the yield of MK of the starting strain is the highest, which is 7.99 mg / g. The yield of MK in the remaining matrices is from large to small, followed by germ and black rice, which are 2.58 mg / g and 2.52 mg / g, respectively. At the same time, the mutant strain Δmpclr4 also has similar performance. The MK yield of the mutant strain Δmpclr4 on the rice flour medium supplemented with oats reached 11.67 mg / g, which is 1.42 times that of the starting strain. The MK yields of the mutant strain Δmpclr4 on the rice flour medium supplemented with germ and black rice are 7.34 mg / g and 6.69 mg / g, respectively, which are 2.84 and 2.65 times that of the starting strain, respectively.
[0097] Total phenols: Figure 6 As shown in Figure b, when the starting strain was fermented on a medium with black rice as a substrate, the total phenol content produced was the highest at 2.43 mg / g, and the other yields were, from highest to lowest, in the solid fermentation medium with germ and oats, which were 1.62 mg / g and 0.85 mg / g, respectively. When the mutant strain Δmpclr4 of Monascus pubescens was fermented on a solid fermentation medium with black rice, germ and oats, the total phenol content produced was 2.93 mg / g, 1.65 mg / g and 1.25 mg / g, respectively, which were all significantly higher than the starting strain, and were 1.21 times, 1.01 times and 1.47 times that of the starting strain, respectively.
[0098] Flavonoids: Figure 6 As shown in Figure c, the starting strain produced flavonoids in fermentation with oats and germ as substrates at contents of 0.51 mg / g and 0.96 mg / g, respectively; the mutant strain Δmpclr4 produced flavonoids in fermentation with oats and germ as substrates at contents of 2.03 mg / g and 2.55 mg / g, respectively, which were 3.98 times and 2.66 times that of the starting strain; the flavonoid content was the highest when fermentation was carried out with black rice as substrate, which was 4.92 mg / g, which was 1.52 times that of the starting strain.
[0099] It can be seen that when the mutant strain Δmpclr4 with high MK yield obtained by the present invention is fermented in a solid fermentation medium prepared by compounding oats, black rice and germ with rice flour respectively, its MK, total phenol and flavonoids yields are greatly improved. Among them, when fermented with oats and rice flour as the solid fermentation medium matrix, the mutant strain Δmpclr4 has the highest MK yield of 11.67 mg / g, which is 1.42 times that of the starting strain Monascus pubescens MS-1, and under this condition, the yields of total phenols and total flavonoids are 1.47 times and 3.98 times that of the starting strain Monascus pubescens MS-1, respectively, so that while increasing the MK yield, the yields of total phenols and total flavonoids are also increased.
[0100] Other parts not described belong to the prior art.
Claims
1. An application of a mutant strain of Monascus pubescens in the fermentation production of functional active substances, characterized in that: The functional active substances include one or more of monacolin K, flavonoids and phenols; wherein, The mutant strain of Monascus pilosula uses Monascus pilosula MS-1 as the starting strain, and knocks out the sequence encoding the SET domain in the histone H3K9 methyltransferase gene mpclr4 on the genome of Monascus pilosula MS-1; the sequence encoding the SET domain in mpclr4 is shown in SEQ ID NO:
2.
2. An application of a mutant strain of Monascus pubescens to improve the yield of monacolin K in a fermentation process, characterized in that: The mutant strain of Monascus pilosula is the mutant strain of Monascus pilosula described in claim 1.
3. The use according to claim 1 or 2, characterized in that: During the fermentation process, the culture medium is a solid fermentation culture medium compounded with cereals and rice flour.
4. The use according to claim 3, characterized in that: In the solid-state fermentation medium, the mass ratio of cereals to rice flour is 1:1-3; the cereals are any one or more of black rice, germ and oats.
5. The use according to claim 4, characterized in that: In the solid-state fermentation medium, the mass ratio of cereals to rice flour is 1:1; the cereals are any one of oats and black rice.
6. The use according to claim 1 or 2, characterized in that: The method for constructing the mutant strain of Monascus pilosula is as follows: preparing protoplasts of Monascus pilosula MS-1, and knocking out a sequence encoding a SET domain in a histone H3K9 methyltransferase gene mpclr4 in the genome of Monascus pilosula MS-1 by combining a CRISPR / Cas9 system and a protoplast transformation method.
7. The use according to claim 6, characterized in that: The preparation method of the protoplasts is as follows: the mycelium of Monascus pubescens MS-1 is hydrolyzed by mixed enzymes, and then the protoplasts are collected and purified.
8. The use according to claim 7, characterized in that: The mixed enzyme is dissolved in an osmotic pressure stabilizer; the components in the mixed enzyme and their mass volume percentages in the osmotic pressure stabilizer are as follows: 0.4% of lytic enzyme, 0.4% of lyase, 1.6% of cellulase and 1.2% of snail enzyme.
9. The use according to claim 8, characterized in that: The pH of the osmotic pressure stabilizer is 5.8; the osmotic pressure stabilizer includes: 0.9M NaCl, 5mM DTT, and 10mM Na2HPO4 / NaH2PO4.
Citation Information
Patent Citations
Monascus strain and application thereof in preparing functional monascus
CN103468585B
